FDA panel backs first new lupus drug in 50 years

FDA panel backs first new lupus drug in 50 years - Connecticut Post: "Only 30 percent of patients studied by Human Genome Sciences responded to the drug, as measured by a comprehensive list of lupus symptoms. The drug did not help African-Americans — who are three times more likely to have lupus than Caucasians"